Bachrodt Amy

SVP, FinanceMaze Therapeutics, Inc. (MAZE) · full profile →Form 4 · filed Mar 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$226K
Net Open-Market Flow
-$226K
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Option exercise(M)5K$10.42$52K18K
Mar 2, 2026Sell(S)1K$44.44$58K17K
Mar 2, 2026Sell(S)4K$45.47$168K13K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2026Option exercise(M)5K$036K
Mar 2, 2026Grant(A)32K$032K
Mar 2, 2026Grant(A)16K$016K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002050422-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly: